                </a></li></ul></div><p><strong>Figure 5.  <span>T-array analysis of CMV-specific cells <em>in vivo.</em>
                  </span></strong></p><a id="article1.body1.sec2.sec6.fig1.caption1.p1" name="article1.body1.sec2.sec6.fig1.caption1.p1"></a><p>
                     <strong>(A)</strong> Peripheral blood was drawn 9 weeks after primary CMV infection of a CMV-seronegative renal transplant recipient, and sorted for CMV+ IFNγ-producing T-cells.</p>
<a id="article1.body1.sec2.sec6.fig1.caption1.p2" name="article1.body1.sec2.sec6.fig1.caption1.p2"></a><p>
                     <strong>(B)</strong> cDNA was amplified using anchored PCR (<em>
                        <a href="#pone.0000055-Douek1">ref. 20</a>
                     </em>).</p>
<a id="article1.body1.sec2.sec6.fig1.caption1.p3" name="article1.body1.sec2.sec6.fig1.caption1.p3"></a><p>
                     <strong>(C)</strong> Vβ's were analyzed by spectratyping and 11 Vβ-families were cloned and sequenced (<em>
                        <a href="#pone.0000055-vanLeeuwen1">ref. 18</a>
                     </em>).</p>
<a id="article1.body1.sec2.sec6.fig1.caption1.p4" name="article1.body1.sec2.sec6.fig1.caption1.p4"></a><p>
                     <strong>(D)</strong> The most prominent Vβ/Jβ combination as identified by (C), i.e. the Vβ6.1/Jβ2.7+pool, was amplified by Vβ6.1-and Jβ2.7-primers and loaded on a hexamer array.</p>
<a id="article1.body1.sec2.sec6.fig1.caption1.p5" name="article1.body1.sec2.sec6.fig1.caption1.p5"></a><p>
                     <strong>(E)</strong> CDR3 regions, clonal frequencies, and joining sequences of the identified Vβ6.1/Jβ2.7+T-cell clones.</p>
<a id="article1.body1.sec2.sec6.fig1.caption1.p6" name="article1.body1.sec2.sec6.fig1.caption1.p6"></a><p>
                     <strong>(F)</strong> Vβ6.1/Jβ2.7-specific T-array with the annealer CTACGAGCAGTACTTCGGG, which matches the germline Jβ-2-7 sequence with 3 nucleotides deleted.</p>
